CRISIL Ltd's Q2 FY27 numbers came in mixed, with revenue of Rs. 1,095.16 Cr (+20.18% YoY) and PAT growth of +5.92% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 23, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 1,095.16 Cr (+20.18% YoY) |
| PAT (Q2) | Rs. 204.54 Cr (+5.92% YoY) |
| EBITDA margin | 27.53% (-136 bps YoY) |
| EPS (Q2) | Rs. 27.97 (+5.91% YoY) |
| Market cap | Rs. 34,744.80 Cr |
| CMP | Rs. 4,751.10 |
CRISIL delivered 20.18% YoY revenue growth with Ratings segment up 28.89% YoY at a stable 44.88% margin, but PAT grew only 5.9% as RAS margin compressed 466 bps YoY to 17.25% and expenses outpaced revenue. Management's directional guidance items (GAC margin stability, accelerated renewals normalization) were validated, though no quantitative guidance exists to benchmark against. The RAS margin trajectory and Q4 normalization dynamics are the key watch items.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.